Fredericks Alger M, Cygan Kamil J, Brown Brian A, Fairbrother William G
Department of Molecular Biology, Cell Biology, and Biochemistry, Brown University, 70 Ship Street, Providence, RI 02903, USA.
Center for Computational Molecular Biology, Brown University, 115 Waterman Street, Providence, RI 02912, USA.
Biomolecules. 2015 May 13;5(2):893-909. doi: 10.3390/biom5020893.
Pre-mRNA splicing is mediated by interactions of the Core Spliceosome and an array of accessory RNA binding proteins with cis-sequence elements. Splicing is a major regulatory component in higher eukaryotes. Disruptions in splicing are a major contributor to human disease. One in three hereditary disease alleles are believed to cause aberrant splicing. Hereditary disease alleles can alter splicing by disrupting a splicing element, creating a toxic RNA, or affecting splicing factors. One of the challenges of medical genetics is identifying causal variants from the thousands of possibilities discovered in a clinical sequencing experiment. Here we review the basic biochemistry of splicing, the mechanisms of splicing mutations, the methods for identifying splicing mutants, and the potential of therapeutic interventions.
前体mRNA剪接由核心剪接体和一系列辅助RNA结合蛋白与顺式序列元件的相互作用介导。剪接是高等真核生物中的主要调控成分。剪接异常是人类疾病的主要原因之一。据信,三分之一的遗传性疾病等位基因会导致异常剪接。遗传性疾病等位基因可通过破坏剪接元件、产生毒性RNA或影响剪接因子来改变剪接。医学遗传学面临的挑战之一是从临床测序实验中发现的数千种可能性中识别出致病变异。在此,我们综述了剪接的基本生物化学、剪接突变的机制、识别剪接突变体的方法以及治疗干预的潜力。